Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$361.28 - $504.76 $438 Million - $612 Million
-1,212,020 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$292.7 - $370.96 $16.3 Million - $20.6 Million
-55,599 Reduced 4.39%
1,212,020 $448 Million
Q3 2020

Nov 13, 2020

SELL
$268.51 - $400.74 $1.62 Million - $2.41 Million
-6,024 Reduced 0.47%
1,267,619 $392 Million
Q2 2020

Aug 07, 2020

SELL
$256.46 - $373.01 $22.3 Million - $32.4 Million
-86,926 Reduced 6.39%
1,273,643 $472 Million
Q1 2020

May 13, 2020

SELL
$209.2 - $335.53 $17.2 Million - $27.6 Million
-82,165 Reduced 5.7%
1,360,569 $372 Million
Q4 2019

Feb 13, 2020

SELL
$288.29 - $335.49 $64.3 Million - $74.8 Million
-222,973 Reduced 13.39%
1,442,734 $479 Million
Q3 2019

Nov 12, 2019

BUY
$266.84 - $378.23 $157 Million - $223 Million
589,196 Added 54.73%
1,665,707 $507 Million
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $15.9 Million - $19.4 Million
-52,752 Reduced 4.67%
1,076,511 $396 Million
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $56.9 Million - $67.1 Million
-208,765 Reduced 15.6%
1,129,263 $351 Million
Q4 2018

Feb 13, 2019

SELL
$272.46 - $366.54 $24.8 Million - $33.4 Million
-91,193 Reduced 6.38%
1,338,028 $401 Million
Q3 2018

Nov 09, 2018

BUY
$279.04 - $367.06 $28.6 Million - $37.7 Million
102,639 Added 7.74%
1,429,221 $525 Million
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $11.9 Million - $15.3 Million
-52,329 Reduced 3.79%
1,326,582 $371 Million
Q1 2018

May 14, 2018

BUY
$209.54 - $253.91 $72.2 Million - $87.5 Million
344,457 Added 33.3%
1,378,911 $326 Million
Q4 2017

Feb 13, 2018

BUY
$202.23 - $230.03 $152 Million - $172 Million
749,468 Added 262.98%
1,034,454 $226 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $49.1 Million - $61 Million
284,986
284,986 $56.8 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.